GSA Capital Partners’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.67M Buy
+65,048
New +$1.51M 0.11% 237
2025
Q2
– Sell
-51,026
Closed -$1.15M – 2072
2025
Q1
$1.15M Sell
51,026
-9,048
-15% -$210K 0.1% 280
2024
Q4
$1.17M Buy
60,074
+9,099
+18% +$180K 0.09% 302
2024
Q3
$928K Buy
50,975
+35,439
+228% +$676K 0.07% 515
2024
Q2
$270K Buy
+15,536
New +$275K 0.02% 1326
2022
Q4
– Sell
-9,531
Closed -$325K – 1804
2022
Q3
$325K Buy
+9,531
New +$352K 0.04% 875

Other funds holding PRVA

GSA Capital Partners's PRVA Position: Q2 2026 in Review

GSA Capital Partners opened a new position in Privia Health (PRVA) in Q2 2026: 65,048 shares worth $1.67M. The stake represents 0.11% of the portfolio and ranks #237 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in PRVA as recently as Q1 2025.

GSA Capital Partners first reported a position in PRVA in Q3 2022 and has held it in 6 quarters since. 302 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • GSA Capital Partners held 65,048 shares of Privia Health worth $1.67M as of Q2 2026.
  • Privia Health was a new GSA Capital Partners position in Q2 2026.
  • Privia Health made up 0.11% of GSA Capital Partners's portfolio in Q2 2026, its #237 holding.
  • GSA Capital Partners first reported a position in Privia Health in Q3 2022 and has held it in 6 quarters since.
  • 302 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.